BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1043 related articles for article (PubMed ID: 34061776)

  • 1. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
    Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
    Bastard P; Orlova E; Sozaeva L; Lévy R; James A; Schmitt MM; Ochoa S; Kareva M; Rodina Y; Gervais A; Le Voyer T; Rosain J; Philippot Q; Neehus AL; Shaw E; Migaud M; Bizien L; Ekwall O; Berg S; Beccuti G; Ghizzoni L; Thiriez G; Pavot A; Goujard C; Frémond ML; Carter E; Rothenbuhler A; Linglart A; Mignot B; Comte A; Cheikh N; Hermine O; Breivik L; Husebye ES; Humbert S; Rohrlich P; Coaquette A; Vuoto F; Faure K; Mahlaoui N; Kotnik P; Battelino T; Trebušak Podkrajšek K; Kisand K; Ferré EMN; DiMaggio T; Rosen LB; Burbelo PD; McIntyre M; Kann NY; Shcherbina A; Pavlova M; Kolodkina A; Holland SM; Zhang SY; Crow YJ; Notarangelo LD; Su HC; Abel L; Anderson MS; Jouanguy E; Neven B; Puel A; Casanova JL; Lionakis MS
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33890986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
    Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
    Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
    Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
    J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.
    Breivik L; Oftedal BE; Bøe Wolff AS; Bratland E; Orlova EM; Husebye ES
    Clin Immunol; 2014 Jul; 153(1):220-7. PubMed ID: 24792136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I.
    Oftedal BE; Wolff AS; Bratland E; Kämpe O; Perheentupa J; Myhre AG; Meager A; Purushothaman R; Ten S; Husebye ES
    Clin Immunol; 2008 Oct; 129(1):163-9. PubMed ID: 18708298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
    Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
    Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
    J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies neutralizing type I IFNs are present in
    Bastard P; Gervais A; Le Voyer T; Rosain J; Philippot Q; Manry J; Michailidis E; Hoffmann HH; Eto S; Garcia-Prat M; Bizien L; Parra-Martínez A; Yang R; Haljasmägi L; Migaud M; Särekannu K; Maslovskaja J; de Prost N; Tandjaoui-Lambiotte Y; Luyt CE; Amador-Borrero B; Gaudet A; Poissy J; Morel P; Richard P; Cognasse F; Troya J; Trouillet-Assant S; Belot A; Saker K; Garçon P; Rivière JG; Lagier JC; Gentile S; Rosen LB; Shaw E; Morio T; Tanaka J; Dalmau D; Tharaux PL; Sene D; Stepanian A; Megarbane B; Triantafyllia V; Fekkar A; Heath JR; Franco JL; Anaya JM; Solé-Violán J; Imberti L; Biondi A; Bonfanti P; Castagnoli R; Delmonte OM; Zhang Y; Snow AL; Holland SM; Biggs C; Moncada-Vélez M; Arias AA; Lorenzo L; Boucherit S; Coulibaly B; Anglicheau D; Planas AM; Haerynck F; Duvlis S; Nussbaum RL; Ozcelik T; Keles S; Bousfiha AA; El Bakkouri J; Ramirez-Santana C; Paul S; Pan-Hammarström Q; Hammarström L; Dupont A; Kurolap A; Metz CN; Aiuti A; Casari G; Lampasona V; Ciceri F; Barreiros LA; Dominguez-Garrido E; Vidigal M; Zatz M; van de Beek D; Sahanic S; Tancevski I; Stepanovskyy Y; Boyarchuk O; Nukui Y; Tsumura M; Vidaur L; Tangye SG; Burrel S; Duffy D; Quintana-Murci L; Klocperk A; Kann NY; Shcherbina A; Lau YL; Leung D; Coulongeat M; Marlet J; Koning R; Reyes LF; Chauvineau-Grenier A; Venet F; Monneret G; Nussenzweig MC; Arrestier R; Boudhabhay I; Baris-Feldman H; Hagin D; Wauters J; Meyts I; Dyer AH; Kennelly SP; Bourke NM; Halwani R; Sharif-Askari NS; Dorgham K; Sallette J; Sedkaoui SM; AlKhater S; Rigo-Bonnin R; Morandeira F; Roussel L; Vinh DC; Ostrowski SR; Condino-Neto A; Prando C; Bonradenko A; Spaan AN; Gilardin L; Fellay J; Lyonnet S; Bilguvar K; Lifton RP; Mane S; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Anderson MS; Boisson B; Béziat V; Zhang SY; Vandreakos E; Hermine O; Pujol A; Peterson P; Mogensen TH; Rowen L; Mond J; Debette S; de Lamballerie X; Duval X; Mentré F; Zins M; Soler-Palacin P; Colobran R; Gorochov G; Solanich X; Susen S; Martinez-Picado J; Raoult D; Vasse M; Gregersen PK; Piemonti L; Rodríguez-Gallego C; Notarangelo LD; Su HC; Kisand K; Okada S; Puel A; Jouanguy E; Rice CM; Tiberghien P; Zhang Q; Cobat A; Abel L; Casanova JL
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34413139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
    Troya J; Bastard P; Planas-Serra L; Ryan P; Ruiz M; de Carranza M; Torres J; Martínez A; Abel L; Casanova JL; Pujol A
    J Clin Immunol; 2021 Jul; 41(5):914-922. PubMed ID: 33851338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.
    Ferré EMN; Schmitt MM; Ochoa S; Rosen LB; Shaw ER; Burbelo PD; Stoddard JL; Rampertaap S; DiMaggio T; Bergerson JRE; Rosenzweig SD; Notarangelo LD; Holland SM; Lionakis MS
    Front Immunol; 2021; 12():720205. PubMed ID: 34504497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do people die from COVID-19?
    Bastard P
    Science; 2022 Feb; 375(6583):829-830. PubMed ID: 35201875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
    Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
    J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy.
    Tóth B; Wolff AS; Halász Z; Tar A; Szüts P; Ilyés I; Erdos M; Szegedi G; Husebye ES; Zeher M; Maródi L
    Clin Endocrinol (Oxf); 2010 May; 72(5):641-7. PubMed ID: 19863576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
    Manry J; Bastard P; Gervais A; Le Voyer T; Rosain J; Philippot Q; Michailidis E; Hoffmann HH; Eto S; Garcia-Prat M; Bizien L; Parra-Martínez A; Yang R; Haljasmägi L; Migaud M; Särekannu K; Maslovskaja J; de Prost N; Tandjaoui-Lambiotte Y; Luyt CE; Amador-Borrero B; Gaudet A; Poissy J; Morel P; Richard P; Cognasse F; Troya J; Trouillet-Assant S; Belot A; Saker K; Garçon P; Rivière JG; Lagier JC; Gentile S; Rosen LB; Shaw E; Morio T; Tanaka J; Dalmau D; Tharaux PL; Sene D; Stepanian A; Mégarbane B; Triantafyllia V; Fekkar A; Heath JR; Franco JL; Anaya JM; Solé-Violán J; Imberti L; Biondi A; Bonfanti P; Castagnoli R; Delmonte OM; Zhang Y; Snow AL; Holland SM; Biggs CM; Moncada-Vélez M; Arias AA; Lorenzo L; Boucherit S; Anglicheau D; Planas AM; Haerynck F; Duvlis S; Ozcelik T; Keles S; Bousfiha AA; El Bakkouri J; Ramirez-Santana C; Paul S; Pan-Hammarström Q; Hammarström L; Dupont A; Kurolap A; Metz CN; Aiuti A; Casari G; Lampasona V; Ciceri F; Barreiros LA; Dominguez-Garrido E; Vidigal M; Zatz M; van de Beek D; Sahanic S; Tancevski I; Stepanovskyy Y; Boyarchuk O; Nukui Y; Tsumura M; Vidaur L; Tangye SG; Burrel S; Duffy D; Quintana-Murci L; Klocperk A; Kann NY; Shcherbina A; Lau YL; Leung D; Coulongeat M; Marlet J; Koning R; Reyes LF; Chauvineau-Grenier A; Venet F; Monneret G; Nussenzweig MC; Arrestier R; Boudhabhay I; Baris-Feldman H; Hagin D; Wauters J; Meyts I; Dyer AH; Kennelly SP; Bourke NM; Halwani R; Sharif-Askari FS; Dorgham K; Sallette J; Sedkaoui SM; AlKhater S; Rigo-Bonnin R; Morandeira F; Roussel L; Vinh DC; Erikstrup C; Condino-Neto A; Prando C; Bondarenko A; Spaan AN; Gilardin L; Fellay J; Lyonnet S; Bilguvar K; Lifton RP; Mane S; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Anderson MS; Boisson B; Béziat V; Zhang SY; Andreakos E; Hermine O; Pujol A; Peterson P; Mogensen TH; Rowen L; Mond J; Debette S; de Lamballerie X; Burdet C; Bouadma L; Zins M; Soler-Palacin P; Colobran R; Gorochov G; Solanich X; Susen S; Martinez-Picado J; Raoult D; Vasse M; Gregersen PK; Piemonti L; Rodríguez-Gallego C; Notarangelo LD; Su HC; Kisand K; Okada S; Puel A; Jouanguy E; Rice CM; Tiberghien P; Zhang Q; Casanova JL; Abel L; Cobat A
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2200413119. PubMed ID: 35576468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes.
    Kisand K; Link M; Wolff AS; Meager A; Tserel L; Org T; Murumägi A; Uibo R; Willcox N; Trebusak Podkrajsek K; Battelino T; Lobell A; Kämpe O; Lima K; Meloni A; Ergun-Longmire B; Maclaren NK; Perheentupa J; Krohn KJ; Scott HS; Husebye ES; Peterson P
    Blood; 2008 Oct; 112(7):2657-66. PubMed ID: 18606876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes.
    Savvateeva EN; Yukina MY; Nuralieva NF; Filippova MA; Gryadunov DA; Troshina EA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.
    Lemarquis A; Campbell T; Aranda-Guillén M; Hennings V; Brodin P; Kämpe O; Blennow K; Zetterberg H; Wennerås C; Eriksson K; Landegren N; Bryceson Y; Berg S; Ekwall O
    J Allergy Clin Immunol; 2021 Jul; 148(1):96-98. PubMed ID: 33892926
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
    Bastard P; Rosen LB; Zhang Q; Michailidis E; Hoffmann HH; Zhang Y; Dorgham K; Philippot Q; Rosain J; Béziat V; Manry J; Shaw E; Haljasmägi L; Peterson P; Lorenzo L; Bizien L; Trouillet-Assant S; Dobbs K; de Jesus AA; Belot A; Kallaste A; Catherinot E; Tandjaoui-Lambiotte Y; Le Pen J; Kerner G; Bigio B; Seeleuthner Y; Yang R; Bolze A; Spaan AN; Delmonte OM; Abers MS; Aiuti A; Casari G; Lampasona V; Piemonti L; Ciceri F; Bilguvar K; Lifton RP; Vasse M; Smadja DM; Migaud M; Hadjadj J; Terrier B; Duffy D; Quintana-Murci L; van de Beek D; Roussel L; Vinh DC; Tangye SG; Haerynck F; Dalmau D; Martinez-Picado J; Brodin P; Nussenzweig MC; Boisson-Dupuis S; Rodríguez-Gallego C; Vogt G; Mogensen TH; Oler AJ; Gu J; Burbelo PD; Cohen JI; Biondi A; Bettini LR; D'Angio M; Bonfanti P; Rossignol P; Mayaux J; Rieux-Laucat F; Husebye ES; Fusco F; Ursini MV; Imberti L; Sottini A; Paghera S; Quiros-Roldan E; Rossi C; Castagnoli R; Montagna D; Licari A; Marseglia GL; Duval X; Ghosn J; ; ; ; ; ; ; ; ; ; ; Tsang JS; Goldbach-Mansky R; Kisand K; Lionakis MS; Puel A; Zhang SY; Holland SM; Gorochov G; Jouanguy E; Rice CM; Cobat A; Notarangelo LD; Abel L; Su HC; Casanova JL
    Science; 2020 Oct; 370(6515):. PubMed ID: 32972996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.